25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

RAC (Race Oncology Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Race Oncology Ltd together

I guess you are interested in Race Oncology Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Race Oncology Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – Race Oncology Ltd’s Price Targets

I'm going to help you getting a better view of Race Oncology Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Race Oncology Ltd

I send you an email if I find something interesting about Race Oncology Ltd.

1. Quick Overview

1.1. Quick analysis of Race Oncology Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Race Oncology Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$0.11
Expected worth in 1 year
A$-0.06
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
A$-0.17
Return On Investment
-14.4%

For what price can you sell your share?

Current Price per Share
A$1.15
Expected price per share
A$0.89 - A$1.3
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Race Oncology Ltd (5 min.)




Live pricePrice per Share (EOD)
A$1.15
Intrinsic Value Per Share
A$-0.72 - A$-0.46
Total Value Per Share
A$-0.61 - A$-0.35

2.2. Growth of Race Oncology Ltd (5 min.)




Is Race Oncology Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$11.5m$16m-$4.5m-39.2%

How much money is Race Oncology Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$8.7m-$6.2m-$2.4m-28.2%
Net Profit Margin-345.2%-316.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Race Oncology Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#591 / 913

Most Revenue
#408 / 913

Most Profit
#498 / 913

Most Efficient
#598 / 913
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Race Oncology Ltd?

Welcome investor! Race Oncology Ltd's management wants to use your money to grow the business. In return you get a share of Race Oncology Ltd.

First you should know what it really means to hold a share of Race Oncology Ltd. And how you can make/lose money.

Speculation

The Price per Share of Race Oncology Ltd is A$1.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Race Oncology Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Race Oncology Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.11. Based on the TTM, the Book Value Change Per Share is A$-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Race Oncology Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.05-4.4%-0.05-4.4%-0.04-3.1%-0.03-2.8%-0.02-1.9%
Usd Book Value Change Per Share-0.03-2.3%-0.03-2.3%-0.04-3.3%0.010.8%0.010.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.2%
Usd Total Gains Per Share-0.03-2.3%-0.03-2.3%-0.04-3.3%0.010.8%0.010.7%
Usd Price Per Share1.15-1.15-0.77-1.18-0.62-
Price to Earnings Ratio-22.94--22.94--21.45--41.36--22.45-
Price-to-Total Gains Ratio-44.19--44.19--20.04-44.05-31.45-
Price to Book Ratio17.31-17.31-8.35-20.58-11.62-
Price-to-Total Gains Ratio-44.19--44.19--20.04-44.05-31.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.7245
Number of shares1380
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.030.01
Usd Total Gains Per Share-0.030.01
Gains per Quarter (1380 shares)-35.9013.27
Gains per Year (1380 shares)-143.6153.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-144-15405343
20-287-298010696
30-431-4420159149
40-574-5860212202
50-718-7300265255
60-862-8740319308
70-1005-10180372361
80-1149-11620425414
90-1292-13060478467
100-1436-14500531520

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%2.013.00.013.3%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%7.03.00.070.0%9.06.00.060.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%2.00.08.020.0%6.00.09.040.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%7.03.00.070.0%9.06.00.060.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Race Oncology Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.041-0.0410%-0.061+48%0.015-370%0.011-490%
Book Value Per Share--0.1050.1050%0.147-28%0.114-8%0.070+50%
Current Ratio--9.3239.3230%20.442-54%16.460-43%11.699-20%
Debt To Asset Ratio--0.0950.0950%0.043+119%0.051+87%0.143-34%
Debt To Equity Ratio--0.1050.1050%0.045+132%0.054+94%2.139-95%
Dividend Per Share----0%-0%-0%0.003-100%
Enterprise Value--332315052.000332315052.0000%233178023.000+43%341165202.800-3%224516562.125+48%
Eps---0.080-0.0800%-0.057-28%-0.052-35%-0.034-57%
Ev To Ebitda Ratio---23.397-23.3970%-18.250-22%-41.372+77%-28.289+21%
Ev To Sales Ratio--83.00783.0070%74.394+12%624.454-87%625.456-87%
Free Cash Flow Per Share---0.055-0.0550%-0.061+12%-0.039-30%-0.025-55%
Free Cash Flow To Equity Per Share---0.025-0.0250%-0.069+175%0.019-233%0.010-351%
Gross Profit Margin--1.0311.0310%1.0330%1.027+0%1.091-5%
Intrinsic Value_10Y_max---0.457--------
Intrinsic Value_10Y_min---0.717--------
Intrinsic Value_1Y_max---0.029--------
Intrinsic Value_1Y_min---0.057--------
Intrinsic Value_3Y_max---0.101--------
Intrinsic Value_3Y_min---0.184--------
Intrinsic Value_5Y_max---0.187--------
Intrinsic Value_5Y_min---0.327--------
Market Cap199780300.000-59%317042650.000317042650.0000%212809450.000+49%325555028.000-3%171255147.600+85%
Net Profit Margin---3.452-3.4520%-3.166-8%-12.589+265%-47.829+1286%
Operating Margin---3.618-3.6180%-4.166+15%-13.422+271%-52.081+1339%
Operating Ratio--4.3424.3420%4.143+5%13.256-67%48.856-91%
Pb Ratio10.910-59%17.31317.3130%8.350+107%20.576-16%11.623+49%
Pe Ratio-14.457+37%-22.942-22.9420%-21.445-7%-41.361+80%-22.447-2%
Price Per Share1.150-59%1.8251.8250%1.225+49%1.874-3%0.986+85%
Price To Free Cash Flow Ratio-20.929+37%-33.214-33.2140%-19.979-40%-58.484+76%-32.114-3%
Price To Total Gains Ratio-27.848+37%-44.193-44.1930%-20.036-55%44.049-200%31.455-240%
Quick Ratio--17.71517.7150%37.181-52%24.675-28%15.761+12%
Return On Assets---0.683-0.6830%-0.373-45%-0.489-28%-0.538-21%
Return On Equity---0.755-0.7550%-0.389-48%-0.518-31%-2.028+169%
Total Gains Per Share---0.041-0.0410%-0.061+48%0.015-370%0.014-405%
Usd Book Value--11536653.24011536653.2400%16056268.830-28%12514092.948-8%7687239.399+50%
Usd Book Value Change Per Share---0.026-0.0260%-0.039+48%0.010-370%0.007-490%
Usd Book Value Per Share--0.0660.0660%0.092-28%0.072-8%0.044+50%
Usd Dividend Per Share----0%-0%-0%0.002-100%
Usd Enterprise Value--209358482.760209358482.7600%146902154.490+43%214934077.764-3%141445434.139+48%
Usd Eps---0.050-0.0500%-0.036-28%-0.033-35%-0.022-57%
Usd Free Cash Flow---6013715.400-6013715.4000%-6710477.130+12%-4235569.254-30%-2711200.023-55%
Usd Free Cash Flow Per Share---0.035-0.0350%-0.039+12%-0.024-30%-0.016-55%
Usd Free Cash Flow To Equity Per Share---0.016-0.0160%-0.043+175%0.012-233%0.006-351%
Usd Market Cap125861589.000-59%199736869.500199736869.5000%134069953.500+49%205099667.640-3%107890742.988+85%
Usd Price Per Share0.725-59%1.1501.1500%0.772+49%1.181-3%0.621+85%
Usd Profit---8706181.680-8706181.6800%-6251757.750-28%-5686508.898-35%-3759435.918-57%
Usd Revenue--2522186.1002522186.1000%1974660.030+28%1057444.164+139%556532.991+353%
Usd Total Gains Per Share---0.026-0.0260%-0.039+48%0.010-370%0.009-405%
 EOD+3 -5MRQTTM+0 -0YOY+19 -195Y+8 -3010Y+19 -21

3.3 Fundamental Score

Let's check the fundamental score of Race Oncology Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-14.457
Price to Book Ratio (EOD)Between0-110.910
Net Profit Margin (MRQ)Greater than0-3.452
Operating Margin (MRQ)Greater than0-3.618
Quick Ratio (MRQ)Greater than117.715
Current Ratio (MRQ)Greater than19.323
Debt to Asset Ratio (MRQ)Less than10.095
Debt to Equity Ratio (MRQ)Less than10.105
Return on Equity (MRQ)Greater than0.15-0.755
Return on Assets (MRQ)Greater than0.05-0.683
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Race Oncology Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.077
Ma 20Greater thanMa 501.114
Ma 50Greater thanMa 1001.181
Ma 100Greater thanMa 2001.286
OpenGreater thanClose1.145
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Race Oncology Ltd

Race Oncology Limited, a clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments. The company's lead product is bisantrene, a small molecule chemotherapeutic that has a clinical history with demonstrated therapeutic benefits in adult and paediatric patients. It is advancing reformulated bisantrene (RC220) to address the unmet need of patients across various oncology indications with a clinical focus on anthracycline combination to deliver cardioprotection and enhanced anticancer activity in solid tumors. The company is also exploring RC220 as a low intensity treatment for acute myeloid leukaemia. In addition, it is investigating the effect of bisantrene on the m6A RNA pathway, following independent research identifying bisantrene as the potent inhibitor of fat mass and obesity-associated protein. The company has collaborations with Astex, City of Hope, MD Anderson, Sheba City of Health, UNC School of Medicine, University of Wollongong, and University of Newcastle. The company was formerly known as Coronado Resources Limited. Race Oncology Limited was incorporated in 2011 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2025-03-18 12:56:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Race Oncology Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -345.2% means that $-3.45 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Race Oncology Ltd:

  • The MRQ is -345.2%. The company is making a huge loss. -2
  • The TTM is -345.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-345.2%TTM-345.2%0.0%
TTM-345.2%YOY-316.6%-28.6%
TTM-345.2%5Y-1,258.9%+913.7%
5Y-1,258.9%10Y-4,782.9%+3,524.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-345.2%-88.1%-257.1%
TTM-345.2%-190.6%-154.6%
YOY-316.6%-199.6%-117.0%
5Y-1,258.9%-336.0%-922.9%
10Y-4,782.9%-488.5%-4,294.4%
4.3.1.2. Return on Assets

Shows how efficient Race Oncology Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • -68.3% Return on Assets means that Race Oncology Ltd generated $-0.68 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Race Oncology Ltd:

  • The MRQ is -68.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -68.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-68.3%TTM-68.3%0.0%
TTM-68.3%YOY-37.3%-31.1%
TTM-68.3%5Y-48.9%-19.4%
5Y-48.9%10Y-53.8%+4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-68.3%-11.9%-56.4%
TTM-68.3%-11.9%-56.4%
YOY-37.3%-11.6%-25.7%
5Y-48.9%-12.7%-36.2%
10Y-53.8%-14.3%-39.5%
4.3.1.3. Return on Equity

Shows how efficient Race Oncology Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • -75.5% Return on Equity means Race Oncology Ltd generated $-0.75 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Race Oncology Ltd:

  • The MRQ is -75.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -75.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-75.5%TTM-75.5%0.0%
TTM-75.5%YOY-38.9%-36.5%
TTM-75.5%5Y-51.8%-23.6%
5Y-51.8%10Y-202.8%+150.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-75.5%-15.6%-59.9%
TTM-75.5%-15.8%-59.7%
YOY-38.9%-14.6%-24.3%
5Y-51.8%-18.0%-33.8%
10Y-202.8%-19.2%-183.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Race Oncology Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Race Oncology Ltd is operating .

  • Measures how much profit Race Oncology Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • An Operating Margin of -361.8% means the company generated $-3.62  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Race Oncology Ltd:

  • The MRQ is -361.8%. The company is operating very inefficient. -2
  • The TTM is -361.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-361.8%TTM-361.8%0.0%
TTM-361.8%YOY-416.6%+54.8%
TTM-361.8%5Y-1,342.2%+980.4%
5Y-1,342.2%10Y-5,208.1%+3,865.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-361.8%-193.7%-168.1%
TTM-361.8%-296.4%-65.4%
YOY-416.6%-206.9%-209.7%
5Y-1,342.2%-367.9%-974.3%
10Y-5,208.1%-475.9%-4,732.2%
4.3.2.2. Operating Ratio

Measures how efficient Race Oncology Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4.34 means that the operating costs are $4.34 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Race Oncology Ltd:

  • The MRQ is 4.342. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.342. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.342TTM4.3420.000
TTM4.342YOY4.143+0.199
TTM4.3425Y13.256-8.914
5Y13.25610Y48.856-35.600
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3422.025+2.317
TTM4.3423.215+1.127
YOY4.1432.982+1.161
5Y13.2564.689+8.567
10Y48.8566.513+42.343
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Race Oncology Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Race Oncology Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.32 means the company has $9.32 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Race Oncology Ltd:

  • The MRQ is 9.323. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.323. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.323TTM9.3230.000
TTM9.323YOY20.442-11.119
TTM9.3235Y16.460-7.137
5Y16.46010Y11.699+4.761
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3233.616+5.707
TTM9.3233.879+5.444
YOY20.4424.483+15.959
5Y16.4605.950+10.510
10Y11.6996.240+5.459
4.4.3.2. Quick Ratio

Measures if Race Oncology Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 17.71 means the company can pay off $17.71 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Race Oncology Ltd:

  • The MRQ is 17.715. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 17.715. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ17.715TTM17.7150.000
TTM17.715YOY37.181-19.466
TTM17.7155Y24.675-6.961
5Y24.67510Y15.761+8.914
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ17.7152.966+14.749
TTM17.7153.336+14.379
YOY37.1814.252+32.929
5Y24.6755.921+18.754
10Y15.7616.474+9.287
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Race Oncology Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Race Oncology Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Race Oncology Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that Race Oncology Ltd assets are financed with 9.5% credit (debt) and the remaining percentage (100% - 9.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Race Oncology Ltd:

  • The MRQ is 0.095. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.095. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.095TTM0.0950.000
TTM0.095YOY0.043+0.051
TTM0.0955Y0.051+0.044
5Y0.05110Y0.143-0.092
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0950.340-0.245
TTM0.0950.340-0.245
YOY0.0430.312-0.269
5Y0.0510.359-0.308
10Y0.1430.382-0.239
4.5.4.2. Debt to Equity Ratio

Measures if Race Oncology Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.5% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Race Oncology Ltd:

  • The MRQ is 0.105. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.105. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.105TTM0.1050.000
TTM0.105YOY0.045+0.059
TTM0.1055Y0.054+0.051
5Y0.05410Y2.139-2.085
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1050.393-0.288
TTM0.1050.428-0.323
YOY0.0450.395-0.350
5Y0.0540.451-0.397
10Y2.1390.493+1.646
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Race Oncology Ltd generates.

  • Above 15 is considered overpriced but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • A PE ratio of -22.94 means the investor is paying $-22.94 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Race Oncology Ltd:

  • The EOD is -14.457. Based on the earnings, the company is expensive. -2
  • The MRQ is -22.942. Based on the earnings, the company is expensive. -2
  • The TTM is -22.942. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.457MRQ-22.942+8.485
MRQ-22.942TTM-22.9420.000
TTM-22.942YOY-21.445-1.497
TTM-22.9425Y-41.361+18.419
5Y-41.36110Y-22.447-18.913
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-14.457-2.074-12.383
MRQ-22.942-2.522-20.420
TTM-22.942-3.216-19.726
YOY-21.445-3.300-18.145
5Y-41.361-6.225-35.136
10Y-22.447-6.955-15.492
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Race Oncology Ltd:

  • The EOD is -20.929. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -33.214. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -33.214. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-20.929MRQ-33.214+12.284
MRQ-33.214TTM-33.2140.000
TTM-33.214YOY-19.979-13.234
TTM-33.2145Y-58.484+25.270
5Y-58.48410Y-32.114-26.370
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-20.929-2.854-18.075
MRQ-33.214-3.511-29.703
TTM-33.214-3.835-29.379
YOY-19.979-4.297-15.682
5Y-58.484-8.217-50.267
10Y-32.114-9.311-22.803
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Race Oncology Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 17.31 means the investor is paying $17.31 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Race Oncology Ltd:

  • The EOD is 10.910. Based on the equity, the company is expensive. -2
  • The MRQ is 17.313. Based on the equity, the company is expensive. -2
  • The TTM is 17.313. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD10.910MRQ17.313-6.404
MRQ17.313TTM17.3130.000
TTM17.313YOY8.350+8.963
TTM17.3135Y20.576-3.262
5Y20.57610Y11.623+8.952
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD10.9101.874+9.036
MRQ17.3132.120+15.193
TTM17.3132.372+14.941
YOY8.3502.453+5.897
5Y20.5763.811+16.765
10Y11.6234.584+7.039
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Race Oncology Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Other Stockholders Equity  -3,889-5,140-9,029-19,312-28,34110,231-18,11018,1100



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets20,229
Total Liabilities1,916
Total Stockholder Equity18,312
 As reported
Total Liabilities 1,916
Total Stockholder Equity+ 18,312
Total Assets = 20,229

Assets

Total Assets20,229
Total Current Assets17,417
Long-term Assets2,812
Total Current Assets
Cash And Cash Equivalents 17,189
Short-term Investments 15,800
Net Receivables 106
Inventory 16
Total Current Assets  (as reported)17,417
Total Current Assets  (calculated)33,111
+/- 15,694
Long-term Assets
Intangible Assets 2,812
Long-term Assets  (as reported)2,812
Long-term Assets  (calculated)2,812
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,868
Long-term Liabilities48
Total Stockholder Equity18,312
Total Current Liabilities
Accounts payable 1,199
Other Current Liabilities 669
Total Current Liabilities  (as reported)1,868
Total Current Liabilities  (calculated)1,868
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)48
Long-term Liabilities  (calculated)0
+/- 48
Total Stockholder Equity
Common Stock66,948
Retained Earnings -57,418
Accumulated Other Comprehensive Income 8,782
Total Stockholder Equity (as reported)18,312
Total Stockholder Equity (calculated)18,312
+/-0
Other
Capital Stock66,948
Cash and Short Term Investments 17,189
Common Stock Shares Outstanding 164,501
Liabilities and Stockholders Equity 20,229
Net Debt -17,189
Net Invested Capital 18,312
Net Working Capital 15,548



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-12-312013-06-302012-12-312012-06-302011-06-30
> Total Assets 
380,251
425,961
360,834
105
289,974
62
124
4,470
6,001
8,240
5,242
5,934
14,246
37,525
26,638
20,229
20,22926,63837,52514,2465,9345,2428,2406,0014,47012462289,974105360,834425,961380,251
   > Total Current Assets 
175,587
306,641
219,536
105
168,926
62
124
4,470
1,751
3,741
1,024
1,997
10,590
34,150
23,545
17,417
17,41723,54534,15010,5901,9971,0243,7411,7514,47012462168,926105219,536306,641175,587
       Cash And Cash Equivalents 
10,305
40,140
19,131
104
25,616
48
21
4,349
1,697
3,710
989
1,731
9,322
6,041
1,920
17,189
17,1891,9206,0419,3221,7319893,7101,6974,349214825,61610419,13140,14010,305
       Short-term Investments 
30,918
60,000
10,000
0
9,992
0
0
0
0
0
0
0
0
27,500
19,600
15,800
15,80019,60027,500000000009,992010,00060,00030,918
       Net Receivables 
48,993
64,364
59,963
8
54,456
14
103
110
2
0
1
49
128
62
1,704
106
1061,70462128491021101031454,456859,96364,36448,993
       Other Current Assets 
84,588
141,219
129,625
1
77,960
14
103
120
52
31
35
217
1,139
547
320
122
1223205471,1392173531521201031477,9601129,625141,21984,588
   > Long-term Assets 
0
0
0
0
0
0
0
3,800
4,250
4,499
4,218
3,937
3,656
3,374
3,093
2,812
2,8123,0933,3743,6563,9374,2184,4994,2503,8000000000
       Property Plant Equipment 
2,848
2,477
2,180
0
1,817
0
0
0
0
0
0
0
0
0
0
0
000000000001,81702,1802,4772,848
       Goodwill 
34,371
34,371
34,371
0
34,371
0
0
0
0
0
0
0
0
0
0
0
0000000000034,371034,37134,37134,371
       Long Term Investments 
77,154
20,381
60,603
0
56,455
0
0
0
0
0
0
0
0
0
0
0
0000000000056,455060,60320,38177,154
       Intangible Assets 
35,861
37,346
25,650
0
17,584
0
0
3,000
4,250
4,499
4,218
3,937
3,656
3,374
3,093
2,812
2,8123,0933,3743,6563,9374,2184,4994,2503,0000017,584025,65037,34635,861
       Long-term Assets Other 
0
0
0
0
0
0
0
800
-4,250
-4,499
-4,218
-3,937
-3,656
-3,374
-3,093
0
0-3,093-3,374-3,656-3,937-4,218-4,499-4,2508000000000
> Total Liabilities 
273,205
331,510
264,983
12
191,008
132
119
392
364
310
192
244
523
1,417
1,152
1,916
1,9161,1521,417523244192310364392119132191,00812264,983331,510273,205
   > Total Current Liabilities 
200,036
253,957
194,387
12
123,907
132
119
392
364
310
192
244
523
1,417
1,152
1,868
1,8681,1521,417523244192310364392119132123,90712194,387253,957200,036
       Short-term Debt 
5,000
0
0
0
0
0
0
5
0
0
0
0
0
0
0
0
0000000050000005,000
       Short Long Term Debt 
5,000
0
0
0
0
0
0
5
0
0
0
0
0
0
0
0
0000000050000005,000
       Accounts payable 
78,710
107,759
96,405
12
73,857
132
119
107
193
205
100
133
312
834
639
1,199
1,19963983431213310020519310711913273,8571296,405107,75978,710
       Other Current Liabilities 
120,852
145,650
97,422
0
49,679
0
0
279
171
105
92
111
211
584
513
669
669513584211111921051712790049,679097,422145,650120,852
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
100
133
312
834
0
48
4808343121331000000000000
       Deferred Long Term Liability 
18,325
20,995
14,744
0
7,071
0
0
0
0
0
0
0
0
0
0
0
000000000007,071014,74420,99518,325
> Total Stockholder Equity
107,046
94,451
95,851
93
98,966
-70
6
4,078
5,637
7,931
5,050
5,690
13,722
36,107
25,486
18,312
18,31225,48636,10713,7225,6905,0507,9315,6374,0786-7098,9669395,85194,451107,046
   Common Stock
99,615
99,539
99,539
110
99,539
110
273
4,663
8,493
14,456
15,423
19,660
31,495
62,017
61,709
66,948
66,94861,70962,01731,49519,66015,42314,4568,4934,66327311099,53911099,53999,53999,615
   Retained Earnings 
7,273
-5,086
-3,997
-17
117
-180
-268
-585
-4,757
-10,811
-13,428
-15,771
-22,466
-33,675
-43,599
-57,418
-57,418-43,599-33,675-22,466-15,771-13,428-10,811-4,757-585-268-180117-17-3,997-5,0867,273
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
160
0
379
-93
698
0
-6
-562
1,901
4,285
3,055
-3,889
-9,029
-28,341
-18,110
0
0-18,110-28,341-9,029-3,8893,0554,2851,901-562-60698-933790160



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue4,003
Cost of Revenue-2,614
Gross Profit1,3901,390
 
Operating Income (+$)
Gross Profit1,390
Operating Expense-14,770
Operating Income-13,381-13,381
 
Operating Expense (+$)
Research Development10,977
Selling General Administrative914
Selling And Marketing Expenses431
Operating Expense14,77012,323
 
Net Interest Income (+$)
Interest Income833
Interest Expense-0
Other Finance Cost-0
Net Interest Income833
 
Pretax Income (+$)
Operating Income-13,381
Net Interest Income833
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-17,823-8,938
EBIT - interestExpense = -14,485
-17,823
-13,819
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-14,485-17,823
Earnings Before Interest and Taxes (EBITDA)-14,203
 
After tax Income (+$)
Income Before Tax-17,823
Tax Provision-0
Net Income From Continuing Ops-13,819-17,823
Net Income-13,819
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses17,384
Total Other Income/Expenses Net-4,442-833
 

Technical Analysis of Race Oncology Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Race Oncology Ltd. The general trend of Race Oncology Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Race Oncology Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Race Oncology Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Race Oncology Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.205 < 1.205 < 1.3.

The bearish price targets are: 0.965 > 0.95 > 0.89.

Know someone who trades $RAC? Share this with them.👇

Race Oncology Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Race Oncology Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Race Oncology Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Race Oncology Ltd. The current macd is -0.01047676.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Race Oncology Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Race Oncology Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Race Oncology Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Race Oncology Ltd Daily Moving Average Convergence/Divergence (MACD) ChartRace Oncology Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Race Oncology Ltd. The current adx is 20.55.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Race Oncology Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Race Oncology Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Race Oncology Ltd. The current sar is 1.289506.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Race Oncology Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Race Oncology Ltd. The current rsi is 50.08. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Race Oncology Ltd Daily Relative Strength Index (RSI) ChartRace Oncology Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Race Oncology Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Race Oncology Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Race Oncology Ltd Daily Stochastic Oscillator ChartRace Oncology Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Race Oncology Ltd. The current cci is 23.29.

Race Oncology Ltd Daily Commodity Channel Index (CCI) ChartRace Oncology Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Race Oncology Ltd. The current cmo is 3.59136664.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Race Oncology Ltd Daily Chande Momentum Oscillator (CMO) ChartRace Oncology Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Race Oncology Ltd. The current willr is -44.7761194.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Race Oncology Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Race Oncology Ltd Daily Williams %R ChartRace Oncology Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Race Oncology Ltd.

Race Oncology Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Race Oncology Ltd. The current atr is 0.07807892.

Race Oncology Ltd Daily Average True Range (ATR) ChartRace Oncology Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Race Oncology Ltd. The current obv is -29,453.

Race Oncology Ltd Daily On-Balance Volume (OBV) ChartRace Oncology Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Race Oncology Ltd. The current mfi is 57.20.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Race Oncology Ltd Daily Money Flow Index (MFI) ChartRace Oncology Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Race Oncology Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Race Oncology Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Race Oncology Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.077
Ma 20Greater thanMa 501.114
Ma 50Greater thanMa 1001.181
Ma 100Greater thanMa 2001.286
OpenGreater thanClose1.145
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Race Oncology Ltd with someone you think should read this too:
  • Are you bullish or bearish on Race Oncology Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Race Oncology Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Race Oncology Ltd

I send you an email if I find something interesting about Race Oncology Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Race Oncology Ltd.

Receive notifications about Race Oncology Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.